Life-Changing Therapies Without A Lifetime Of Development

Precision for Medicine (PFM) offers an integrated suite of services that spans global CRO capabilities, central laboratory services, and IVD & CDx regulatory development consulting. Their CRO services are tailored for small-to-mid-sized innovators, combining advanced trial design, biomarker-driven strategies, decentralized trial solutions, and functional service provider (FSP) models to accelerate timelines and optimize capital efficiency, particularly in oncology, rare diseases, cell, and gene therapies.

Their central lab services are purpose-built for biomarker-driven clinical trials, with global infrastructure supporting customized kitting, sample logistics, and biobanking. Proprietary platforms like Epiontis ID^®, ApoStream^®, and QuartzBio^® integrate assay development, molecular profiling, and advanced bioinformatics to streamline data collection and enhance trial outcomes. PFM’s IVD & CDx Regulatory Consulting team brings expertise across 350+ global submissions, offering comprehensive support from early diagnostic strategy through global submissions and lifecycle management. They specialize in patient stratification strategies, significant risk determinations, CLIA/CLSI validations, and global compliance. This integrated approach bridges scientific, regulatory, and commercial milestones, guiding sponsors through complex pathways efficiently to bring novel therapies and diagnostics to market faster.